217 related articles for article (PubMed ID: 3954821)
21. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
Komarek J
Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
[TBL] [Abstract][Full Text] [Related]
22. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
23. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
24. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Hayashi N; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models.
Yamamoto S; Hayashi N; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):630-4. PubMed ID: 9205777
[TBL] [Abstract][Full Text] [Related]
27. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
Kates RA; Zaggy AP; Norfleet EA; Heath KR
Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
[TBL] [Abstract][Full Text] [Related]
28. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
Hansing CE; Folts JD; Afonso S; Rowe GG
J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
[No Abstract] [Full Text] [Related]
29. Effects of hydralazine on cardiopulmonary function in canine low-pressure pulmonary edema.
Ghignone M; Girling L; Prewitt RM
Anesthesiology; 1983 Sep; 59(3):187-90. PubMed ID: 6881582
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
Polakowski JS; King AJ; Campbell TJ; Nelson RA; Preusser LC; Kempf-Grote AJ; Marsh KC; Gintant GA; Cox BF; Mittelstadt SW
J Cardiovasc Pharmacol; 2009 Dec; 54(6):543-51. PubMed ID: 19770671
[TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
Dage RC; Roebel LE; Hsieh CP; Woodward JK
J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
[TBL] [Abstract][Full Text] [Related]
33. Regional blood flow and cardiac responses to hydralazine.
Spokas EG; Wang HH
J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
[No Abstract] [Full Text] [Related]
34. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
35. The effect of vasopressin on oxygen availability.
Berk JL; Hagen JF; Fried VJ
Ann Surg; 1979 Apr; 189(4):439-41. PubMed ID: 443898
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405).
Caravaggi AM; Sardi A; Baldoli E; Di Francesco GF; Luca TC
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):139-48. PubMed ID: 869636
[TBL] [Abstract][Full Text] [Related]
37. Effects of hydralazine on regional blood flow in conscious dogs.
Chelly JE; Doursout MF; Begaud B; Tsao CC; Hartley CJ
J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
39. [Effect of prostaglandin A1 on systemic and regional hemodynamics in dogs].
Flerov EV; Ismailov ShI
Farmakol Toksikol; 1977; 40(4):407-12. PubMed ID: 902738
[TBL] [Abstract][Full Text] [Related]
40. Whole body and regional hemodynamic effects of minoxidil in the conscious dog.
Humphrey SJ; Zins GR
J Cardiovasc Pharmacol; 1984; 6(6):979-88. PubMed ID: 6084789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
